UMIN-CTR History
Name： UMIN ID：
| Unique ID issued by UMIN | C000000179 |
|---|---|
| Receipt number | R000000244 |
| Scientific Title | Phase III trial of doxorubicin / cyclophosphamide (AC), docetaxel (D), and alternating AC and D (AC-D) as front-line chemotherapy for metastatic breast cancer: Japan Clinical Oncology Group trial (JCOG9802) |
| Date of disclosure of the study information | 2005/09/12 |
| Last modified on | 2014/02/21 14:21:06 |
| No. | Disposal | Last modified on | Item of update | |
|---|---|---|---|---|
| 1 | Insert | 2005/09/12 16:39:20 | ||
| 2 | Update | 2005/10/18 11:21:32 | Secondary IDs Study ID_1 Org. issuing International ID_1 Org. issuing International ID_1 |
|
| 3 | Update | 2007/01/10 14:57:01 | Email1 |
|
| 4 | Update | 2008/03/25 19:33:08 | Recruitment status Date of closure to data entry Date trial data considered complete Date analysis concluded |
|
| 5 | Update | 2008/08/08 12:03:26 | Email1 |
|
| 6 | Update | 2012/06/20 11:57:35 | Acronym |
|
| 7 | Update | 2014/02/21 14:21:06 | Publication of results URL related to results and publications Results Results |
